FDA Authorizes Expanded Use for REGEN-COV mAb

The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

Aug 05, 2021 | Guest Author

  • Webinar, COVID-19, Immunization

    NACCHO COVID-19 Webinar: Pfizer-BioNTech COVID-19 Vaccine Training & Education

    Join the Pfizer-BioNTech COVID-19 Vaccine Training & Education webinar on Tuesday, January 12, 3:00-4:00 pm ET.

    Jan 05, 2021 | Beth Hess

  • Tools & Resources, COVID-19, Emergency Response

    Alternate Care Site Toolkit

    ASPR TRACIE has released an updated Alternate Care Site Toolkit to help address potential capacity and capability gaps in health care...

    Jul 02, 2020 | Beth Hess

  • COVID-19

    FDA Authorizes Expanded Use for REGEN-COV mAb

    The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

    Aug 05, 2021 | Guest Author

    Webinar, COVID-19, Immunization

    NACCHO COVID-19 Webinar: Pfizer-BioNTech COVID-19 Vaccine Training & Education

    Join the Pfizer-BioNTech COVID-19 Vaccine Training & Education webinar on Tuesday, January 12, 3:00-4:00 pm ET.

    Jan 05, 2021 | Beth Hess

    Tools & Resources, COVID-19, Emergency Response

    Alternate Care Site Toolkit

    ASPR TRACIE has released an updated Alternate Care Site Toolkit to help address potential capacity and capability gaps in health care systems during the COVID-19 pandemic.

    Jul 02, 2020 | Beth Hess

    3 Newsletters1200 1
    Back to Top